Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Zollinger-Ellison syndrome].

H D Becker

    Wiener Klinische Wochenschrift
    |February 17, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Zollinger-Ellison syndrome (ZES) is a rare condition caused by gastrin-producing tumors, often malignant. Treatment focuses on managing stomach acid and surgically removing tumors when possible.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Encapsulation of Islets in Rough Surface, Hydroxymethylated Polysulfone Capillaries Stimulates VEGF Release and Promotes Vascularization after Transplantation.

    Cell transplantation·2017
    Same author

    [Recommendations for training courses in bronchoscopy].

    Pneumologie (Stuttgart, Germany)·2011
    Same author

    EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration.

    The European respiratory journal·2009
    Same author

    [Endobronchial treatment of malignant airway obstructions].

    Deutsche medizinische Wochenschrift (1946)·2009
    Same author

    [Endobronchial ultrasound for diagnosis of the mediastinum].

    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2007
    Same author

    Lactate down-regulates cellular poly(ADP-ribose) formation in cultured human skin fibroblasts.

    European journal of clinical investigation·2007
    Same journal

    [Vaccination of immunocompromised individuals: Expert opinion - update 2026].

    Wiener klinische Wochenschrift·2026
    Same journal

    Systematic review of clinical evidence for Kneipp medicine.

    Wiener klinische Wochenschrift·2026
    Same journal

    Pelvic resections in primary sarcomas : Surgical outcomes and survival analysis of 75 patients.

    Wiener klinische Wochenschrift·2026
    Same journal

    Jungmediziner*innen am Start: 11. Workshop für den medizinischen Nachwuchs.

    Wiener klinische Wochenschrift·2026
    Same journal

    Stellungnahme der ÖGP zur geplanten Gesetzesnovelle zum Nichtraucherschutzgesetz.

    Wiener klinische Wochenschrift·2026
    Same journal

    MUW researcher of the month: Dr. Moritz Schaefer.

    Wiener klinische Wochenschrift·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Gastroenterology
    • Surgical Oncology

    Background:

    • Zollinger-Ellison syndrome (ZES) originates from gastrin-producing tumors, primarily in the pancreas.
    • These tumors exhibit a high incidence of malignancy.
    • ZES is characterized by excessive gastric acid secretion, leading to severe peptic ulcers, reflux esophagitis, and diarrhea.

    Purpose of the Study:

    • To outline the etiology, clinical presentation, diagnostic methods, and therapeutic strategies for Zollinger-Ellison syndrome.
    • To differentiate ZES from other causes of hypergastrinemia.
    • To emphasize the importance of timely diagnosis and appropriate management due to the high malignancy rate.

    Main Methods:

    • Diagnostic differentiation relies on provocative tests, notably the secretin test.

    Related Experiment Videos

  • Therapeutic approaches include symptomatic management of gastric hypersecretion.
  • Surgical intervention is considered for specific tumor types and locations.

    • Main Results:

    • Gastric hypersecretion is the hallmark clinical manifestation of ZES.
    • Provocative tests are crucial for accurate diagnosis.
    • Treatment strategies vary based on tumor characteristics and patient condition.

    Conclusions:

    • Early diagnosis and management of ZES are critical due to the high malignancy potential of gastrinomas.
    • Symptomatic treatment with H2-receptor antagonists is a primary approach.
    • Tumor resection is the preferred treatment for benign pancreatic tumors and duodenal gastrinomas.